Valuation: Macrogen, Inc.

Market Cap 135B 101M 90.17M 84.13M 76.41M 144M 9.76B 145M 1.01B 395M 4.96B 379M 371M 15.96B P/E 2024
-21.7x
P/E 2025 90.2x
Enterprise Value 186B 139M 124M 116M 105M 198M 13.4B 199M 1.39B 542M 6.82B 520M 509M 21.92B EV / Sales 2024
1.49x
EV / Sales 2025 1.19x
Free-Float
79.78%
Yield 2024
1.82%
Yield 2025 2.96%
1 day-0.32%
1 week+1.62%
Current month+2.70%
1 month+2.03%
6 months-20.52%
Current year-25.61%
1 week 12,220
Extreme 12220
12,790
1 month 11,500
Extreme 11500
12,790
Current year 10,440
Extreme 10440
20,900
1 year 10,440
Extreme 10440
20,900
3 years 10,440
Extreme 10440
26,700
5 years 10,440
Extreme 10440
31,250
10 years 10,440
Extreme 10440
54,900
Manager TitleAgeSince
Chief Executive Officer 59 30/03/2025
Chief Executive Officer 74 30/03/2025
Director of Finance/CFO 52 -
Director TitleAgeSince
Chairman 74 09/10/2010
Director/Board Member 59 -
Director/Board Member 53 30/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
09/04/25 Buy

Chief Executive Officer

1,100 0.0101%
07/02/25 Others 2,192 0.0202%
23/01/25 Others

Chief Financial Officer

95 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
-0.32%+1.62%-18.98%-29.45% 101M
+4.16%+4.16%+49.37%+94.17% 74.68B
-12.71%-13.31%+6.17%+56.23% 58.7B
-1.32%+1.39%+4.33%+32.49% 48.36B
+0.50%-2.14%+331.33%+702.20% 43.05B
-0.72%-3.99%+28.50%+29.94% 42.48B
+0.34%-0.52%+6.56%+109.35% 41.39B
-0.11%+1.96%+9.19%+52.66% 31.29B
-0.50%-3.10%-10.19%-14.35% 23.93B
-3.32%-10.86%-37.32%+316.28% 22.22B
Average -1.43%-1.80%+36.90%+134.95% 38.62B
Weighted average by Cap. -1.56%-1.56%+49.76%+145.68%

Financials

2024 2025
Net sales 136B 101M 90.56M 84.49M 76.74M 145M 9.8B 146M 1.02B 397M 4.99B 381M 372M 16.03B 195B 146M 130M 122M 110M 208M 14.1B 209M 1.46B 570M 7.17B 547M 535M 23.05B
Net income -7.6B -5.68M -5.07M -4.73M -4.3M -8.09M -549M -8.15M -56.85M -22.21M -279M -21.31M -20.85M -898M 2.03B 1.52M 1.35M 1.26M 1.15M 2.16M 147M 2.18M 15.18M 5.93M 74.55M 5.69M 5.57M 240M
Net Debt 38.17B 28.49M 25.46M 23.75M 21.57M 40.63M 2.76B 40.94M 285M 112M 1.4B 107M 105M 4.51B 50.44B 37.65M 33.64M 31.39M 28.51M 53.69M 3.64B 54.1M 377M 147M 1.85B 141M 138M 5.95B
Projected Income Statement - Annual - Macrogen, Inc.
Logo Macrogen, Inc.
Macrogen Inc is a Korea-based company principally engaged in the genome analysis business. The Company’s main products include DNA sequencing, oligo synthesis, and microarray analysis. The Company also provides various genome-based research services such as single-cell analysis and metagenome analysis. In addition, the Company is engaged in the operation of genetically engineered mouse production, clinical genome analysis services, personal genome analysis services, and microbiome analysis services. The Company sells its products and services in domestic and overseas markets.
Employees
473
Date Price Change Volume
08/10/26 ₩12,180.00 -2.33% 19,804
07/10/26 ₩12,470.00 -0.64% 29,293
06/10/26 ₩12,550.00 -0.32% 20,315
02/10/26 ₩12,590.00 -0.71% 13,735
01/10/26 ₩12,680.00 +3.76% 24,417

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Macrogen, Inc.
  1. Stock Market
  2. Stocks
  3. A038290 Stock